Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
19 Apr 2013 | Africa | Market Research
Analysis of the South African Medical Imaging Market
Improved Diagnosis and Treatment Through Adoption of New Technologies
This research service presents the findings on the South African Medical Imaging Market. The research service presents an overview of the healthcare and medical imaging industry structure of the country. The market size and growth of the total medical imaging market, including five main device segments that characterise the market are presented. A ...
$6,950.00 -
21 Dec 2016 | Africa | Market Research
African Pharmaceuticals Market, Forecast to 2020
Assessing Market Potential with a Focus on Kenya and Nigeria
The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest re...
$4,950.00 -
30 Oct 2018 | Africa | Market Research
Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...
$1,500.00 -
10 Apr 2019 | Africa | Market Research
Generic Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022
Greater Regulatory Control and a Shift of Focus Away from Costly and Branded Drugs will Increase Generic Drugs’ Market Share
The African continent grapples with a huge burden of communicable diseases, particularly HIV/AIDS, tuberculosis, and malaria. With African governments facing major health financing challenges, a significant proportion of these disease areas are financed by global aid organizations that are also helping in poverty eradication in the continent. Paral...
$3,000.00
